New Harmony Union (NHU) Holding Group Co

What New Harmony Union (NHU) Holding Group Co does

New Harmony Union (NHU) Holding Group Co., Ltd. is a privately-held diversified Chinese industrial conglomerate founded in 1988 and headquartered in Xinchang, Zhejiang Province. The group operates through four business pillars: fine chemicals (via listed subsidiary Zhejiang NHU Co., Ltd., 002001.SZ, producing vitamins, carotenoids, fragrances, PPS/PPA engineering plastics, and APIs), pharmaceuticals and medical devices (via listed subsidiary Beijing Foyou Pharma Co., Ltd., 601089.SH, covering cardiovascular, metabolic, CNS, anti-infective, and urology products), high-end chemical equipment (Zhejiang Deli Equipment Co., Ltd., serving petrochemical and energy customers with pressure vessels and FPSO modules), and education (Zhejiang Yuexiu University of Foreign Languages). The group owns five major production bases across Xinchang, Shangyu, Shandong (Weifang), Heilongjiang (Suihua), and Tianjin, plus an international subsidiary in Singapore, and reports a workforce of 17,000+ with total assets above 500 billion CNY as of 2023.

The group's core technology rests on dual 'Chemical+' and 'Bio+' platforms that underpin vertically-integrated production of vitamins (A, E, D3), amino acids (methionine), aroma chemicals (citral, linalool), engineering plastics (PPS, PPA, nylon), and pharmaceutical actives — with multiple products being the first domestically developed at industrial scale. Revenue is generated primarily through direct B2B enterprise sales (Zhejiang NHU exports to 100+ countries via regional offices), national pharmaceutical distribution through hospitals and retail channels (Foyou Pharma), and custom-engineered equipment sales to petrochemical and energy customers globally (Deli Equipment, including FPSO deliveries to NOV). Zhejiang NHU reported 216 billion CNY of revenue in 2024 (up 42.95% YoY) and 111 billion CNY in 1H 2025 (up 12.76% YoY), with the group as a whole serving customers across nutrition, food and beverage, pharmaceutical, automotive, electronics, and energy end-markets.

The business model is anchored by proprietary process IP (two National Technological Invention Second Prizes, in 2011 and 2016), scale-driven cost advantages across 15,000+ acres of manufacturing footprint, and a deep regulatory moat (US FDA zero-defect inspection at Shangyu NHU in May 2026, US FDA GMP at Anhui Foyou, ASME U+U2 certification at Deli Equipment, 78 generic-drug consistency evaluations and 12 national volume-based procurement wins at Foyou Pharma). The 'Teacher Culture' management philosophy, traced to the group's origins as a school-run factory, supports talent attraction and retention across the conglomerate.

Name

New Harmony Union (NHU) Holding Group Co

Legal name

新和成控股集团有限公司

Website

https://cnhugroup.com

Company type

Private

Founded year

1988

Operating status

Operating

Short description

NHU Holding Group is a privately-held Chinese conglomerate operating fine chemicals (vitamins, methionine, PPS/PPA), pharmaceuticals (Foyou Pharma, generics and medical devices), high-end chemical equipment, and education, with five production bases in China and customers in 100+ countries.

Ownership category

akta.pro rank

Product category

Specialty/Fine Chemicals Manufacturing

NAICS

Chemical Manufacturing (325), All Other Chemical Product and Preparation Manufacturing (32599)

SIC

Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800), Pharmaceutical Preparations (2834)

akta.pro primary industry

Bulk Industrial Solvents (IMAEAAAE)

Keywords

• Fine chemicals manufacturing
• Nutritional vitamins production
• Engineering plastics materials
• Generic pharmaceuticals manufacturing
• Chemical process equipment

Headquarters

HQ city

Xinchang

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Fine Chemicals (Nutritional Products): Revenue from vitamins (VA, VE, VD3), nutritional supplements, feed additives, and health ingredients. Major product lines include vitamin E, vitamin A, biotin, coenzyme Q10, and carotenoid pigments sold globally to nutrition and health companies.
2. Fragrances and Flavors: Production and sales of linalool, leaf alcohol, and other aroma chemicals for food, beverage, and personal care industries. Products serve both domestic Chinese and international markets.
3. New Materials (PPS, PPA): Engineering plastics including polyphenylene sulfide (PPS) and high-temperature polyamide (PPA) sold to automotive, electronics, and industrial manufacturing customers.
4. Pharmaceutical Products: Revenue from generic pharmaceutical manufacturing including cardiovascular, diabetes, CNS, and anti-infective medications. Products sold through hospital and retail pharmacy channels in China and internationally.
5. Medical Devices: Medical device development, production and sales including clinical nursing products, urology devices, and respiratory care products.
6. Chemical Equipment: High-end pressure vessels, heat exchangers, reactors and complete equipment sets for chemical, petrochemical and energy industries.
7. Education Services: Tuition and educational services from Zhejiang Yuexiu University offering undergraduate programs across 17 foreign languages and multiple disciplines. Non-profit education philosophy.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

NHU Holding Group is a diversified industrial manufacturer producing fine chemicals (vitamins A/E, amino acids, fragrances, PPS/PPA engineering plastics), generic pharmaceuticals and medical devices (through Beijing Foyou Pharma), high-end chemical process equipment (through Zhejiang Deli Equipment), and operating Zhejiang Yuexiu University. The group runs five production bases across China and serves enterprise customers in over 100 countries with vertically integrated manufacturing of functional chemicals, drug products, and industrial equipment.

Product overview

NHU Holding Group Co., Ltd. is a diversified industrial conglomerate operating across four main business segments: Fine Chemicals (dominated by Zhejiang NHU Company Limited producing nutritional products, fragrances, flavors, and new materials like PPS), Medicine & Health (led by Beijing Foyou Pharma Co., Ltd. covering pharmaceuticals and medical devices), Machinery/Equipment (through Zhejiang Deli Equipment Co., Ltd. manufacturing high-end chemical equipment), and Education (via Zhejiang Yuexiu University). The group owns two listed companies (Zhejiang NHU - 002001 and Beijing Foyou Pharma - 601089) and operates five major production bases across China. The company provides functional chemical products and solutions to customers in over 100 countries, serving industries including nutritional health, transportation, energy, smart living, engineering manufacturing, and environmental protection.

Differentiator

Problem solved

Functional benefit

Brands

• 福元 (Foyou): Pharmaceutical brand under Beijing Foyou Pharma Co., Ltd., covering cardiovascular, diabetes, anti-infection, respiratory, and other therapeutic areas. Notable products include Daqilaqinjian (达格列净片), Esomeprazole Magnesium (艾司奥美拉唑镁肠溶干混悬剂), and Hengshufu (恒舒福).
• 福元易下 (Foyou Yixia)
• 浙江新和成尼龙材料
• 德力 (DELI)

Products and services

• Nutritional Products (Vitamins, Coenzyme Q10, Carotenoids)

Quantifiable outcome

• Vitamin E and Vitamin A market share ranked among top 3 globally
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Ten partnerships are on record, tiered major and core.

• National Oilwell Varco (NOV)majorStrategic or Co-development Partner · 1 January 2026Strategic equipment supply partnership for energy industry: Deli Equipment successfully delivered 6 FPSO processing units to NOV for overseas oilfield projects. First major overseas energy equipment order demonstrating international quality standards.
• Shanghai Stock ExchangecoreOthers · 1 January 2022Beijing Foyou Pharma listed on Shanghai Stock Exchange main board (stock code 601089).
• Jiangnan University (江南大学)majorStrategic or Co-development Partner · 1 January 2019Project cooperation agreement signed in 2019 for bio-fermentation and biotechnology research collaboration.
• Royal DSM (帝斯曼)coreStrategic or Co-development Partner · 1 January 2015Joint venture in engineering plastics: DSM NHU Engineering Plastics (浙江) Co., Ltd. established in 2015 to develop new materials applications and strengthen development-to-production chain. Partnership focused on accelerating new materials development and applications.
• Chinese Academy of Sciences Shanghai Organic Chemistry Institute (中科院上海有机所)coreStrategic or Co-development Partner · 1 January 2014Cooperation framework agreement signed in 2014 to build integrated technology innovation platform leveraging talents, technology, and capital resources. Joint research in advanced organic chemistry and chemical engineering.
• Zhejiang University (浙江大学)coreStrategic or Co-development Partner · 1 January 2012NHU-Zhejiang University Joint R&D Center established 2012; NHU also holds stake in Zhejiang University Innovation Technology Research Institute. Long-term collaboration in chemical engineering, biotechnology, and materials science.
• Technical University of Denmark (丹麦科技大学)majorStrategic or Co-development Partner · 1 January 2012International research partnership for advanced chemical technology development and talent exchange programs.
• Shenzhen Stock ExchangecoreOthers · 1 January 2004Zhejiang NHU listed on SME board (stock code 002001) as first A-share on SME board in China.
• Sinopec (中石化)majorStrategic or Co-development PartnerUpstream and downstream cooperation in chemical production, technology exchange, and market development for petrochemical products.
• CNPC (中石油)majorStrategic or Co-development PartnerStrategic cooperation in chemical engineering equipment and materials supply for petroleum industry applications.

Scale indicators13 records

Recent moves28 records

Expansion highlights6 records

Direct peers

• Royal DSM (now dsm-firmenich): Global leader in nutrition and health (vitamins, premixes, APIs) and the most direct head-to-head competitor for NHU's vitamin A/E and nutrition ingredients. DSM was a JV partner of NHU in engineering plastics (DSM NHU Engineering Plastics, est. 2015), reflecting deep operational overlap.
• Zhejiang Medicine Co., Ltd. Domestic Chinese vitamin and nutritional ingredient manufacturer (vitamin A, vitamin E, carotenoids) and one of NHU's closest direct competitors in the China specialty chemicals market. The two companies compete head-to-head on price, capacity, and quality in global vitamin exports.
• Kingfa Sci & Tech Co., Ltd. Chinese listed leader in modified plastics, engineering plastics (PA, PPS, PBT), and polymer materials - the most direct domestic competitor for NHU's PPS and PPA new materials business, both serving automotive, electronics, and industrial customers.

Broad incumbents

• Lonza Group AG: Swiss contract development and manufacturing organization and fine chemicals producer. Overlaps with NHU's API manufacturing and chemical equipment customer base; comparable as a major fine chemicals and life-sciences inputs supplier at much greater scale.
• DIC Corporation: Japan-based global manufacturer of pigments, performance materials, and polymers including PPS resins. Comparable as a PPS materials supplier to automotive and electronics customers, overlapping directly with NHU's polyphenylene sulfide business.
• Toray Industries, Inc. Japanese global specialty chemicals and advanced materials conglomerate producing engineering plastics, fibers, and fine chemicals. Comparable to NHU's new materials and fine chemicals segments, with a much broader portfolio and global footprint.
• Evonik Industries AG: German specialty chemicals company with a leading global position in methionine (METAMINO), a direct competitor to NHU's newly-built Shandong methionine capacity. Also produces amino acids, specialty additives, and polymer materials overlapping with NHU's portfolio.
• BASF SE: Largest global chemical company with a major Nutrition & Health division producing vitamins, carotenoids, and aroma ingredients. As a broad incumbent, BASF competes with NHU across multiple product lines including vitamins, fragrances, and engineering plastics, but at much greater scale and across many other chemical categories.

Emerging players

• CSPC Pharmaceutical Group Limited: Leading Chinese pharmaceutical conglomerate with strong generic drug and innovative drug portfolios, and a major participant in China's national volume-based procurement. Overlaps with Foyou Pharma in cardiovascular, anti-infective, and CNS therapy areas.
• Sino Biopharmaceutical Limited: Major Chinese listed pharmaceutical company producing generic and innovative drugs across cardiovascular, oncology, and other therapeutic areas. Comparable to NHU's Foyou Pharma subsidiary as a domestic pharma peer with broad generic-drug portfolios and active generic consistency evaluation pipelines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Harmony Union (NHU) Holding Group Co